<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the efficacy of four different treatment regimens (sulphonylurea and <z:chebi fb="0" ids="6801">metformin</z:chebi>+/-<z:chebi fb="0" ids="2376">acarbose</z:chebi> versus <z:chebi fb="0" ids="5383">glimepiride</z:chebi> and <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> versus <z:chebi fb="0" ids="5383">glimepiride</z:chebi> and bedtime <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> insulin versus multiple actrapid and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> insulin injections) in poorly controlled type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> subjects on hs-CRP, VCAM-1 and AGE at 4, 8 and 12 weeks of treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Multiple insulin injections rapidly improved HbA(1c) by 0.6+/-0.9% (p&lt;0.005), 1.2+/-1.3% (p&lt;0.0005) and 1.3+/-1.4% (p&lt;0.0005) at week 4, at week 8 and week 12, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Subjects who continued their existing combination treatment of sulphonylurea, <z:chebi fb="0" ids="6801">metformin</z:chebi>+/-<z:chebi fb="0" ids="2376">acarbose</z:chebi> also showed a significant reduction in HbA(1c) (p&lt;0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>Although effective in reducing glycemic parameters, there was no reduction in CRP levels in either treatment group </plain></SENT>
<SENT sid="4" pm="."><plain>The treatment regimen consisting of <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> and <z:chebi fb="0" ids="5383">glimepiride</z:chebi> significantly lowered hs-CRP by -2.6 (3.9) mg/L (p&lt;0.05) at week 12 in spite of no improvement in blood <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>AGE improved in <z:hpo ids='HP_0000001'>all</z:hpo> groups irrespective of type of treatment, glycaemic control and CRP levels </plain></SENT>
<SENT sid="6" pm="."><plain>Our data indicate rapid glycaemic control alone does not necessarily result in improvement in markers of <z:mp ids='MP_0001845'>inflammation</z:mp> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients </plain></SENT>
</text></document>